Patents Examined by L. Schenkman
  • Reversal of glucocorticoid-induced skin atrophy
    Patent number: 5019569
    Abstract: The present invention is directed to the topical administration of a retinoid-containing pharmaceutical composition for reversing the effects of glucocorticoid-induced skin atrophy.
    Type: Grant
    Filed: August 31, 1989
    Date of Patent: May 28, 1991
    Assignee: Ortho Pharmaceutical Corporation
    Inventors: Albert M. Kligman, James A. Mezick, Robert J. Capetola